JP2016528273A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2016528273A5 JP2016528273A5 JP2016535487A JP2016535487A JP2016528273A5 JP 2016528273 A5 JP2016528273 A5 JP 2016528273A5 JP 2016535487 A JP2016535487 A JP 2016535487A JP 2016535487 A JP2016535487 A JP 2016535487A JP 2016528273 A5 JP2016528273 A5 JP 2016528273A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally
- compound according
- substituted
- group
- alkyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 150000001875 compounds Chemical class 0.000 claims 20
- 125000000217 alkyl group Chemical group 0.000 claims 8
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 7
- 229910052736 halogen Inorganic materials 0.000 claims 4
- 150000002367 halogens Chemical class 0.000 claims 4
- 150000003839 salts Chemical class 0.000 claims 4
- 239000011780 sodium chloride Substances 0.000 claims 4
- 125000001072 heteroaryl group Chemical group 0.000 claims 3
- 239000008194 pharmaceutical composition Substances 0.000 claims 3
- 125000006570 (C5-C6) heteroaryl group Chemical group 0.000 claims 2
- 125000005213 alkyl heteroaryl group Chemical group 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 239000000126 substance Substances 0.000 claims 2
- 201000011510 cancer Diseases 0.000 claims 1
- 239000000969 carrier Substances 0.000 claims 1
- 230000032823 cell division Effects 0.000 claims 1
- 125000004093 cyano group Chemical group *C#N 0.000 claims 1
- 125000002944 cyanoaryl group Chemical group 0.000 claims 1
- RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Substances C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 125000000714 pyrimidinyl group Chemical group 0.000 claims 1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP13181577 | 2013-08-23 | ||
EP13181577.1 | 2013-08-23 | ||
PCT/EP2014/067859 WO2015025019A1 (en) | 2013-08-23 | 2014-08-21 | New 6-alkynyl pyridine |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2016528273A JP2016528273A (ja) | 2016-09-15 |
JP2016528273A5 true JP2016528273A5 (US07794700-20100914-C00125.png) | 2017-09-28 |
JP6338665B2 JP6338665B2 (ja) | 2018-06-06 |
Family
ID=49003719
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016535487A Active JP6338665B2 (ja) | 2013-08-23 | 2014-08-21 | 新規6−アルキニルピリジン |
Country Status (7)
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3125920B1 (en) | 2014-04-04 | 2020-12-23 | Del Mar Pharmaceuticals | Dianhydrogalactitol, diacetyldianhydrogalactitol or dibromodulcitol to treat non-small-cell carcinoma of the lung and ovarian cancer |
AR101479A1 (es) | 2014-08-11 | 2016-12-21 | Boehringer Ingelheim Int | Derivados de 6-alquinil-piridina |
EP3458441B1 (en) | 2016-05-19 | 2021-01-20 | Boehringer Ingelheim International GmbH | Process for the manufacture of 6-alkynyl-pyridine derivatives |
CN109152843A (zh) | 2016-05-20 | 2019-01-04 | 豪夫迈·罗氏有限公司 | Protac抗体缀合物及其使用方法 |
AU2018241944A1 (en) | 2017-03-31 | 2019-08-15 | Boehringer Ingelheim International Gmbh | Anticancer combination therapy |
EP3886842A1 (en) | 2018-11-26 | 2021-10-06 | Debiopharm International SA | Combination treatment of hiv infections |
TW202043466A (zh) | 2019-01-25 | 2020-12-01 | 德商百靈佳殷格翰國際股份有限公司 | 編碼ccl21之重組棒狀病毒 |
CA3151770A1 (en) | 2019-09-25 | 2021-04-01 | Silvano BRIENZA | Dosing regimens for treatment of patients with locally advanced squamous cell carcinoma |
TW202210499A (zh) | 2020-06-03 | 2022-03-16 | 德商百靈佳殷格翰國際股份有限公司 | 編碼CD80胞外域Fc融合蛋白之重組桿形病毒 |
WO2023056069A1 (en) | 2021-09-30 | 2023-04-06 | Angiex, Inc. | Degrader-antibody conjugates and methods of using same |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AR048927A1 (es) * | 2004-04-07 | 2006-06-14 | Novartis Ag | Compuestos heterociclicos como inhibidores de proteinas de apoptosis (iap); composiciones farmaceuticas que los contienen y su uso en el tratamiento de una enfermedad proliferativa |
WO2008073306A1 (en) | 2006-12-07 | 2008-06-19 | Novartis Ag | Organic compounds |
DE102007036075A1 (de) * | 2007-08-01 | 2009-02-05 | Bayer Healthcare Ag | Prodrugs und ihre Verwendung |
US20110105436A1 (en) * | 2008-03-10 | 2011-05-05 | Auckland Uniservices Limited | Heteroaryl compounds, compositions, and methods of use in cancer treatment |
US8859541B2 (en) * | 2012-02-27 | 2014-10-14 | Boehringer Ingelheim International Gmbh | 6-alkynylpyridines |
-
2014
- 2014-08-20 US US14/463,692 patent/US9278978B2/en active Active
- 2014-08-21 WO PCT/EP2014/067859 patent/WO2015025019A1/en active Application Filing
- 2014-08-21 JP JP2016535487A patent/JP6338665B2/ja active Active
- 2014-08-21 EP EP14753105.7A patent/EP3036228B1/en active Active
- 2014-08-21 UY UY35710A patent/UY35710A/es unknown
- 2014-08-22 TW TW103129098A patent/TW201605798A/zh unknown
- 2014-08-22 AR ARP140103170A patent/AR097435A1/es unknown